Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.91 |
| ▸ | FAAH | O00519 | 1/20 | 0.91 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.91 |
| ▸ | CNR2 | P34972 | 1/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Linoleoylethanolamide SCHEMBL653623 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL30306296 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL6259736 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL14106445 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL14864036 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Linoleoylethanolamide SCHEMBL5145794 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL5412597 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL14106447 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL17097089 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Linoleoylethanolamide SCHEMBL13110450 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1HPGDTRPV1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1294411-A4 | A NOVEL TREATMENT FOR COUGH | UNIV CALIFORNIA (US) | 2006-02-01 | — | — | EP | claimed |
| US-6974568-B2 | Treatment for cough | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-13 | — | — | US | claimed |
| EP-1294411-A1 | A NOVEL TREATMENT FOR COUGH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-03-26 | — | — | EP | claimed |
| US-20020035150-A1 | Novel treatment for cough | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2002-03-21 | — | — | US | claimed |
| WO-2001089589-A1 | A NOVEL TREATMENT FOR COUGH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-11-29 | — | — | WO | claimed |
| EP-0670826-B1 | FATTY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RES DEV CO (IL) | 2000-04-26 | — | — | EP | claimed |
| US-5618955-A | ANTIINFLAMMATORY AGENTS, ANALGESICS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1997-04-08 | — | — | US | claimed |
| EP-0670826-A4 | FATTY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | YISSUM RES DEV CO (IL) | 1996-08-14 | — | — | EP | claimed |
| JP-H08504195-A | — | — | 1996-05-07 | — | — | JP | claimed |
| EP-0670826-A1 | FATTY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1995-09-13 | — | — | EP | claimed |
| WO-1994012466-A1 | FATTY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1994-06-09 | — | — | WO | claimed |
| US-20110280807-A1 | Methods and Models for Stress-Induced Analgesia | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2011-11-17 | — | — | US | disclosed |
| US-20090082435-A1 | Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-03-26 | — | — | US | disclosed |
| US-20080103209-A1 | Compounds And Methods For Treating Non-Inflammatory Pain Using Ppar Alpha Agonists | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-05-01 | — | — | US | disclosed |
| WO-2006116703-A2 | METHODS AND MODELS FOR STRESS-INDUCED ANALGESIA | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2006-11-02 | — | — | WO | disclosed |
| US-6974568-B2 | Treatment for cough | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-13 | — | — | US | disclosed |
| EP-1294411-A1 | A NOVEL TREATMENT FOR COUGH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-03-26 | — | — | EP | disclosed |
| US-20020035150-A1 | Novel treatment for cough | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2002-03-21 | — | — | US | disclosed |
| WO-2001089589-A1 | A NOVEL TREATMENT FOR COUGH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-11-29 | — | — | WO | disclosed |
| EP-0670826-B1 | FATTY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RES DEV CO (IL) | 2000-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103209-A1 | Compounds And Methods For Treating Non-Inflammatory Pain Using Ppar Alpha Agonists | FAAH, CNR2, FAAH2 | CNR1 4/4885ALDH1A1 967/4885HPGD 187/4885 |
| US-20090082435-A1 | Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders | MGLL, PNLIP, LIPC | CNR1 273/4885ALDH1A1 1248/4885HPGD 358/4885 |
| US-20020035150-A1 | Novel treatment for cough | CNR1, CNR2, TRPV1 | CNR1 1/4885ALDH1A1 3682/4885HPGD 2184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.